CDTX
Price
$12.68
Change
+$0.87 (+7.37%)
Updated
May 2, 6:59 PM EST
6 days until earnings call
GOVX
Price
$1.46
Change
-$0.02 (-1.35%)
Updated
May 2, 6:59 PM EST
Ad is loading...

CDTX vs GOVX ᐉ Comparison: Which is Better to Invest?

Header iconCDTX vs GOVX Comparison
Open Charts CDTX vs GOVXBanner chart's image
Cidara Therapeutics
Price$12.68
Change+$0.87 (+7.37%)
Volume$41.81K
CapitalizationN/A
GeoVax Labs
Price$1.46
Change-$0.02 (-1.35%)
Volume$6.3K
CapitalizationN/A
View a ticker or compare two or three
CDTX vs GOVX Comparison Chart

Loading...

CDTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GOVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CDTX vs. GOVX commentary
May 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a StrongSell and GOVX is a Sell.

COMPARISON
Comparison
May 03, 2024
Stock price -- (CDTX: $12.68 vs. GOVX: $1.42)
Brand notoriety: CDTX and GOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 53% vs. GOVX: 35%
Market capitalization -- CDTX: $57.34M vs. GOVX: $3.28M
CDTX [@Biotechnology] is valued at $57.34M. GOVX’s [@Biotechnology] market capitalization is $3.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileGOVX’s FA Score has 0 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • GOVX’s FA Score: 0 green, 5 red.
According to our system of comparison, CDTX is a better buy in the long-term than GOVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while GOVX’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 6 bearish.
  • GOVX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GOVX is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а -2.46% price change this week, while GOVX (@Biotechnology) price change was -3.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.22%. For the same industry, the average monthly price growth was -1.75%, and the average quarterly price growth was +1238.84%.

Reported Earning Dates

CDTX is expected to report earnings on Aug 08, 2024.

GOVX is expected to report earnings on May 02, 2024.

Industries' Descriptions

@Biotechnology (+5.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CDTX with price predictions.
OPEN
A.I.dvisor published
a Summary for GOVX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CDTX($57.3M) has a higher market cap than GOVX($3.28M). CDTX YTD gains are higher at: 1496.977 vs. GOVX (-73.777).
CDTXGOVXCDTX / GOVX
Capitalization57.3M3.28M1,748%
EBITDAN/AN/A-
Gain YTD1496.977-73.777-2,029%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt4.36MN/A-
FUNDAMENTALS RATINGS
CDTX vs GOVX: Fundamental Ratings
CDTX
GOVX
OUTLOOK RATING
1..100
7470
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
38100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3450
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GOVX's Valuation (49) in the null industry is in the same range as CDTX (53) in the Biotechnology industry. This means that GOVX’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's Profit vs Risk Rating (38) in the Biotechnology industry is somewhat better than the same rating for GOVX (100) in the null industry. This means that CDTX’s stock grew somewhat faster than GOVX’s over the last 12 months.

GOVX's SMR Rating (99) in the null industry is in the same range as CDTX (100) in the Biotechnology industry. This means that GOVX’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is in the same range as GOVX (50) in the null industry. This means that CDTX’s stock grew similarly to GOVX’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as GOVX (100) in the null industry. This means that CDTX’s stock grew similarly to GOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXGOVX
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
89%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CDTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
GOVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSIT178.425.20
+3.00%
Insight Enterprises
ERAS2.150.06
+2.87%
Erasca
SCS12.250.22
+1.83%
Steelcase
ICCM1.180.01
+0.85%
IceCure Medical Ltd
ADP242.03-5.30
-2.14%
Automatic Data Processing

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
+7.37%
BPTSY - CDTX
92%
Closely correlated
+1.47%
IVVD - CDTX
36%
Loosely correlated
-2.07%
CPRX - CDTX
35%
Loosely correlated
-1.18%
CABA - CDTX
33%
Poorly correlated
+1.53%
TRAW - CDTX
30%
Poorly correlated
-2.79%
More

GOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOVX has been loosely correlated with TOVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GOVX jumps, then TOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOVX
1D Price
Change %
GOVX100%
-2.07%
TOVX - GOVX
54%
Loosely correlated
+2.94%
MAIA - GOVX
32%
Poorly correlated
+7.88%
OCUP - GOVX
27%
Poorly correlated
+12.80%
ATNF - GOVX
26%
Poorly correlated
+0.50%
CDTX - GOVX
26%
Poorly correlated
+7.37%
More